Thank you, Mr. Chair.
Dr. Vigo, I appreciate that you've also now shared your concerns about the fact that Health Canada's bureaucracy has stood in the way of access to an evidence-based drug, which is injectable naltrexone.
Can you describe why it is important that Health Canada finally act to make this drug available?